PMID: 7522322Sep 13, 1994Paper

Omega 3 polyunsaturated fatty acid modulates dihydropyridine effects on L-type Ca2+ channels, cytosolic Ca2+, and contraction in adult rat cardiac myocytes

Proceedings of the National Academy of Sciences of the United States of America
S PepeE Lakatta

Abstract

The effect of docosahexaenoic acid (DHA; C22:6) on dihydropyridine (DHP) interaction with L-type Ca2+ channel current (ICa), cytosolic Ca2+ (Cai), and cell contraction in isolated adult rat cardiac myocytes was studied. The DHP L-type Ca(2+)-channel blocker nitrendipine (10 nM) reduced peak ICa (measured by whole-cell voltage clamp from -45 to 0 mV) and reduced the amplitude of the Ca2+ transient (measured as the transient in indo-1 fluorescence, 410/490 nm) and the twitch amplitude (measured via photodiode array) during steady-state electrical stimulation (0.5 Hz). The DHP L-type Ca2+ channel agonist BAY K 8644 (10 nM) significantly increased ICa, the amplitude of the Cai transient, and contraction. When cells were exposed to DHA (5 microM) simultaneously with either BAY K 8644 or nitrendipine, the drug effects were abolished. Arachidonic acid (C20:4) at 5 microM did not block the inhibitory effects of nitrendipine nor did it prevent the potentiating effects of BAY K 8644. DHA modulation of DHP action could be reversed by cell perfusion with fatty acid-free bovine serum albumin at 1 mg/ml. Neither DHA nor arachidonic acid alone (5 microM) had any apparent effect on the parameters measured. DHA (5 microM) had no influence over ...Continue Reading

References

Jul 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·J M HuangM Bacaner
Mar 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·H HallaqA Leaf
Jun 1, 1992·American Heart Journal·P L McLennanJ S Charnock
Mar 24, 1993·Biochemical Pharmacology·C Dettbarn, P Palade
Jan 1, 1993·The Journal of Membrane Biology·G E TaffetR J Bick
Feb 1, 1993·Circulation Research·D S Damron, M Bond

❮ Previous
Next ❯

Citations

Apr 4, 1996·European Journal of Pharmacology·P McLennanR Head
Jul 12, 2005·Progress in Biophysics and Molecular Biology·Sébastien JudéJean-Yves Le Guennec
Oct 29, 2003·Chemistry and Physics of Lipids·William Stillwell, Stephen R Wassall
Dec 24, 1997·Brain Research. Brain Research Reviews·H R Arias
Sep 2, 1999·Prostaglandins, Leukotrienes, and Essential Fatty Acids·A L StollW E Severus
Aug 23, 2001·The Journal of Nutritional Biochemistry·W R. LeifertE J. McMurchie
Jul 4, 2002·Comparative Biochemistry and Physiology. Part A, Molecular & Integrative Physiology·Edward G Lakatta, Steven J Sollott
Jan 5, 2001·British Journal of Pharmacology·M B EnglerR Sievers
Sep 6, 2000·Clinical and Experimental Pharmacology & Physiology·S Pepe
Dec 11, 2002·The European Journal of Neuroscience·Benchamaporn Seebungkert, Joseph W Lynch
Oct 11, 1994·Proceedings of the National Academy of Sciences of the United States of America·J X Kang, A Leaf
Nov 21, 1995·Proceedings of the National Academy of Sciences of the United States of America·Y F XiaoA Leaf
Apr 25, 1995·Proceedings of the National Academy of Sciences of the United States of America·J X KangA Leaf
Apr 16, 1996·Proceedings of the National Academy of Sciences of the United States of America·J X Kang, A Leaf
May 31, 2003·Journal of Cardiovascular Pharmacology·Hisakazu OgitaMasafumi Kitakaze
Jun 1, 2000·Australian and New Zealand Journal of Medicine·C B SingletonT J Campbell
Oct 2, 2001·Bioscience, Biotechnology, and Biochemistry·N NakanoH Yoshizumi
Apr 15, 1997·Proceedings of the National Academy of Sciences of the United States of America·Y F XiaoA Leaf
Oct 6, 2011·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·Allan R MottramJonathan C Makielski
Nov 11, 2008·Epilepsy & Behavior : E&B·Ameer Y TahaW McIntyre Burnham
Nov 8, 2007·Annals of the New York Academy of Sciences·Salvatore Pepe
Jan 5, 2002·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·R B SinghA Gvozdjakova
Feb 24, 2001·Critical Care Clinics·G P Zaloga, P Marik
Mar 10, 2005·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Ram B SinghKuniaki Otsuka
May 8, 2009·Cell Calcium·Mandy L Roberts-CrowleyAnn R Rittenhouse
May 17, 2008·Journal of Molecular and Cellular Cardiology·Céline MarionneauJeanne M Nerbonne
Sep 17, 2003·Revista brasileira de psiquiatria : orgão oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latina·Christopher Young, Andrés Martin
Jun 28, 2011·JPEN. Journal of Parenteral and Enteral Nutrition·Ozer MakaySinan Ersin
Jul 27, 2001·Pediatrics International : Official Journal of the Japan Pediatric Society·M SkalskiW P Zeller

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
H HallaqA Leaf
Proceedings of the National Academy of Sciences of the United States of America
J X Kang, A Leaf
Proceedings of the National Academy of Sciences of the United States of America
Y F XiaoA Leaf
Proceedings of the National Academy of Sciences of the United States of America
G E BillmanA Leaf
© 2021 Meta ULC. All rights reserved